Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Longeveron Inc LGVN

Healthcare Biotechnology
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:LGVN)

Longeveron, Selected as a StartUp Health Alzheimer's Disease Moonshot Company, Will Participate in StartUp Health Apollo House During JPM Healthcare Week 2026

GlobeNewswire December 29, 2025

Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy

GlobeNewswire December 17, 2025

Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum

GlobeNewswire December 3, 2025

Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging

GlobeNewswire December 2, 2025

Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer's Disease Presented at the Clinical Trials on Alzheimer's Disease Conference (CTAD 2025)

GlobeNewswire December 1, 2025

Longeveron Laromestrocel Data in Alzheimer's Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD 2025)

GlobeNewswire November 19, 2025

Longeveron Granted U.S. Patent for Method of Treating Aging-related Frailty in Patients with Inflammaging Using its Proprietary Stem Cell Therapy

GlobeNewswire November 12, 2025

Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire November 4, 2025

Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025

GlobeNewswire October 28, 2025
View More News ››

Opinion & Analysis (NDAQ:LGVN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LGVN)

LGVN....Nr on P.O

done
Iseneschal - July 18, 2024

LGVN.....Guess what....u've all been had.... Again!

  Longeveron Announces Exercise of Warrants for $4.4 Million Gross Proceeds   2024-06-17 05:39 ET - News Release...
Iseneschal - June 17, 2024

LGVN.....early a.m runner yesterday on back to back NR's

Big volume & price action this a.m ....22 million shs & trading at $2.45 I'd say some of the warrants are being exercised at...
Iseneschal - June 13, 2024

RE:LGVN.....ahhhh isn't that nice of the CEO to give the .....

What did I tell you on April 08th ????  That was "tomorrows News in advance" !!!!! Here is todays news...
Iseneschal - April 19, 2024

LGVN.....What did I tell you????

Say god-night ..... Richard !!!!!!!!!!!!!!!!
Iseneschal - April 8, 2024

LGVN.... Has to hold here at $3.20 or else....

It's done ; ) GLTA  Me no position
Iseneschal - April 8, 2024
View more Bullboard ››

Pasofino Gold Limited

Pasofino Gold Limited

Pasofino Gold Limited, a Canada-based mineral exploration company, engages in the acquisition, exploration, and development ...
View More »

Podcasts